CIK 0001944885 · Non-accelerated filer<br>Emerging growth company
Apollomics Inc.
Sign in to watch- Ticker
- APLM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 1-650-209-4055
- Business address
- 668 ARROW GRAND CIR, SUITE 206, COVINA, CA, 91772
Securities
- APLM Class A Ordinary Shares Nasdaq
- APLMW Warrant Nasdaq
- 6-K Event Report of Foreign Issuer
- 4/A Option exercise Chief Operating Officer acquired 5,000 shares (option exercise)
- 4/A Shares withheld for taxes Chief Financial Officer gave up 3,416 shares (to pay taxes)
- 4/A Option exercise Director acquired 500 shares (option exercise)
- 4 Shares withheld for taxes Chief Financial Officer gave up 3,416 shares (to pay taxes)
- 4 Option exercise Director acquired 500 shares (option exercise)
- 4 Option exercise Chief Operating Officer acquired 5,000 shares (option exercise)
- 4 Option exercise Director acquired 500 shares (option exercise)
- 4 Option exercise Director acquired 500 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Executive Officer acquired 5,000 shares (option exercise)
- 424B3 Offering Prospectus
- 4 Option exercise Director acquired 500 shares (option exercise)
- D Other Notice of Sales of Unregistered Securities
- 4 Open-market buy Chief Operating Officer bought 20,000 shares at $15.00 ($300,000)
- 4 Open-market buy Chief Financial Officer bought 26,667 shares at $15.00 ($400,005)
- 4 Open-market buy Chief Executive Officer bought 536,667 shares at an average $14.07 ($7,550,004)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 6-K Event Report of Foreign Issuer
Page 1 of 10 · 184 filings